Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
BioBlast®
Biosimilars Deals 2023
Diversity
Masterclasses
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Patents
PipCast®
PTE
Trade Marks
Webinars

Eisai and Biogen’s Leqembi® Intravenous Infusion (lecanemab) to Launch in Japan 20 December 2023

Dec 12, 2023

Eisai and Biogen announced that Leqembi® intravenous infusion (lecanemab) will be launched in Japan on 20 December 2023, after it was scheduled on the Japan National Health Insurance (NHI) Drug Price List.  Leqembi® intravenous infusion was approved in Japan on 25 September 2023 for slowing progression of mild cognitive impairment and mild dementia due to Alzheimer’s disease.